Federer Jessica 4
4 · Sage Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Federer Jessica
Director
Transactions
- Award
Stock Options (Right to buy)
2023-03-16+19,894→ 19,894 totalExercise: $43.64Exp: 2033-03-16→ Common Stock (19,894 underlying)
Footnotes (1)
- [F1]All of the shares subject to the option vest in equal monthly installments during the 36 months following March 16, 2023 (the "Grant Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Grant Date, subject to the reporting person's continued service as a director of the issuer through such date.